Skip to content

Focused Manual Ingest Batch 6

Scope

This audit records a private-wiki source-review pass completed on 2026-04-30.

The pass deep-ingested 10 previously provisional source notes. The purpose was to strengthen ILC2 regulatory architecture around trafficking, costimulation, immune egress, allergen memory, and human AIT monitoring, while adding gut/mucosal-labeled ILC3 mechanism context for IL-17D/CD93, reciprocal TF networks, NPM1/OXPHOS, and PDGF-D species divergence.

Sources Promoted

Knowledge-Layer Changes

  • Added S1P-dependent inflammatory ILC2 trafficking, ILC2 OX40L costimulation, ILC2-derived LIF immune-egress control, and epigenetic ILC2 memory to the ILC2 hub and topic pages.
  • Added human blood AIT immune-monitoring context while preserving the blood compartment boundary.
  • Added gut/mucosal-labeled ILC3 regulation branches: IL-17D/CD93, reciprocal TF-network identity, NPM1-p65-TFAM mitochondrial OXPHOS, and PDGF-D receptor/species divergence.
  • Added one lung ILC review as an orientation source rather than primary mechanistic evidence.

Interpretation Limits

  • Gut and mucosal ILC3 mechanisms remain extrapulmonary context unless direct lung data are cited.
  • Human AIT evidence is blood immune-monitoring evidence, not lung tissue causality.
  • Mouse ILC2 trafficking, OX40L, LIF, and memory findings should preserve model, stimulus, and compartment labels.